SMS Reminders for Positive FOBT Follow-up

NCT03642652 | Completed

• 1 other identifier: 01-023-03-16
• Study Type: interventional
• Target: 470
• Locations: 0 countries
• Sites: N/A

Brief Summary

A randomized controlled trial to examine the effect of 3 mobile telephone text message reminders on followup colonoscopy 120 days after a positive fecal occult blood test among Meuhedet members aged 50-74 who tested positive in 2016.

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

• Follow-up colonoscopy 120 days after a positive fecal occult blood test

  Completion of colonoscopy

  120 days after positive FOBT

Study Arms (2)

SMS

EXPERIMENTAL

Each patient in the intervention group also received an automated text message up to a week after the positive FOBT result. The text read: "Hello. There is a lab test result ready for you. Contact your physician for an explanation of the findings." Two additional automated text message reminders were sent to the patient at 2 weeks and 1 month reading, "Hello, This is a reminder. It is essential that you contact your physician if you have not already done so."

Behavioral: SMS

Control

NO INTERVENTION

Routine care

Interventions

SMS BEHAVIORAL

Text reminders to mobile telephone

Also known as: mobile text reminder

SMS

Eligibility Criteria

• Age: 50 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• positive fecal occult blood test (FOBT) in 2016
• agreed to receive SMS from healthcare provider

You may not qualify if:

• Existing oncology diagnosis
• personal or family history of colorectal cancer
• colonoscopy up to 10 years prior to FOBT

Sponsors & Collaborators

• Meuhedet. Healthcare Organization: lead

Related Publications (1)

• Azulay R, Valinsky L, Hershkowitz F, Magnezi R. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Feb 5;7(2):e11114. doi: 10.2196/11114.

  PMID: 30720439 DERIVED

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Masking Details: Participants were not aware of the trial. Only Intervention arm participants received text reminders
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Randomisation into Intervention and control groups. Text message sent to Intervention group. No intervention in control group

Study Record Dates

• First Submitted: August 21, 2018
• First Posted: August 22, 2018
• Study Start: April 1, 2016
• Primary Completion: April 1, 2017
• Study Completion: May 1, 2017
• Last Updated: August 24, 2018

Record last verified: 2018-08

Data Sharing

• IPD Sharing: Will not share